Objectives: The purpose of this study was to assess the 3-year outcome of coronary artery
bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) using sirolimus …

Objectives: We compared the 5-year outcomes of diabetic patients with multivessel disease
treated with sirolimus-eluting stents (SES), bare-metal stents (BMS), and coronary artery …

Background: ARTS-II was designed to evaluate the sirolimus-eluting stent (SES) versus
ARTS-I. The objective of this analysis is to assess the safety and efficacy of the SES in …

Abstract Background: The FREEDOM (Future Revascularization Evaluation in Patients with
Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for …

Background In some randomized trials comparing revascularization strategies for patients
with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than …

Objectives: To explore the clinical performance of a strategy of revascularization by
percutaneous coronary intervention (PCI) with drug‐eluting stent (DES) in diabetic patients …

BACKGROUND: Some prior randomized trials suggested that revascularization of diabetic
patients by coronary artery bypass grafting (CABG) produced results superior to balloon …

Background Our aims were to compare coronary artery bypass grafting (CABG) and stenting
for the treatment of diabetic patients with multivessel coronary disease enrolled in the …

Background: There are few data to compare the long-term efficacy of sirolimus-eluting stent
(SES) and off-pump coronary artery bypass grafting (OPCAB) for diabetic patients with …

Background: The prospective, randomized FREEDOM (Comparison of Two Treatments for
Multivessel Coronary Artery Disease in Individuals With Diabetes) trial found coronary artery …